As a result of the revision and discussion of the RHD-DGs during the Board of the Network meeting (13-14 November 2019, Barcelona), a total of 70 RHD-DG has been identified. The Myeloid malignancies subnetwork includes 9 disease groups.
RHD-DGs and disorders included are currently under revision for final approval.
|Diseases Groups and entities included|
|Acute myeloid leukemia (Other than Acute promyelocytic leukemia and germline predisposition)|
|Acute promyelocytic leukemia|
|Myeloproliferative neoplasm (Other than Chronic myeloid leukemia and Hypereosinophilic syndrome)*|
|Chronic myeloid leukemia|
|Myelodysplastic/myeloproliferative disease including CMML|
|Myeloid neoplasms with germline predisposition|